Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

NCT05491200 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1656

Enrollment

OTHER

Sponsor class

Conditions

ST Elevated Myocardial Infarction
Dual Antiplatelet Therapy

Interventions

DRUG: Prasugrel based short DAPT
DRUG: Prasugrel based standard DAPT
DEVICE: OCT guided revascularization
DEVICE: Angio guided revascularization

Sponsor

Research Maatschap Cardiologen Rotterdam Zuid

Collaborators

[object Object]